Company profile: Astex Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of novel small-molecule therapeutics discovery and development using its pioneering fragment-based drug discovery platform, Pyramidβ’. The UK-based company has built a pipeline of molecularly-targeted oncology drugs, with three in clinical trials and others in discovery and pre-clinical stages.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Astex Pharmaceuticals
Lobe Sciences
HQ: Canada
Website
- Description: Provider of life sciences focused on transformational medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Lobe Sciences company profile β
NeuroSigma
HQ: United States
Website
- Description: Provider of trigeminal nerve stimulation (TNS) medical devices and therapies for neurologic and psychiatric disorders. The company commercializes its TNS technology with a pipeline targeting epilepsy, depression, ADHD, and PTSD. Products include the Monarch eTNS System, a non-drug treatment device for pediatric ADHD used during sleep under caregiver supervision.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full NeuroSigma company profile β
Stellate
HQ: Canada
Website
- Description: Provider of networking, database, recording, review, and analysis systems for electrical activity from the brain, serving EEG laboratories, epilepsy monitoring units, sleep laboratories, and intensive care units; engaged in the development, design, and manufacture of products for brain activity recording and analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Stellate company profile β
Compass Pathways
HQ: United Kingdom
Website
- Description: Provider of psilocybin-based mental health therapies and research for treatment-resistant depression, PTSD, and anorexia nervosa. Offers COMP360 psilocybin treatment administered with psychological support, a therapist training programme, a Discovery Center for preclinical studies, and support for investigator-initiated studies, conducting clinical trials and research on psilocybin therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Compass Pathways company profile β
Vernalis
HQ: United Kingdom
Website
- Description: Provider of fragment- and structure-based drug discovery, research collaborations with pharmaceutical, biotechnology and academic partners, and KNIME open-source software nodes for data access, cheminformatics and structural informatics; develops Chk1 and Hsp90 inhibitors. A revenue-generating development-stage pharmaceutical company advancing promising product candidates along a commercially focused path to market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Vernalis company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Astex Pharmaceuticals
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Astex Pharmaceuticals
2.2 - Growth funds investing in similar companies to Astex Pharmaceuticals
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Astex Pharmaceuticals
4.2 - Public trading comparable groups for Astex Pharmaceuticals
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β